Abstract
Objective: Prosody, an important aspect of spoken language, is defined as the emphasis placed on certain syllables, changes in tempo or timing, and variance in pitch and intonation. Most studies investigating expression and comprehension of prosody have focused primarily on emotional prosody and less extensively on supralexical prosody. The distinction is indeed important, as the latter conveys information such as interrogative or assertive mode, whereas the former delivers emotional connotation, such as happiness, anger, and sadness. These functions appear to rely on distinct neuronal networks, supported by functional neuroimaging studies that show activation of the right hemisphere, specifically in the right inferior frontal area during emotional detection.
Conclusion: This review summarizes the studies conducted on prosody impairment in Alzheimer's disease and other dementias, with emphasis on experiments designed to investigate the emotional vs. the supralexical aspect of speech production. We also discussed the available tools validated to test and quantify the prosodic impairment.
Keywords: Alzheimer's disease, dementia, frontotemporal dementia, language, mild cognitive impairment, prosody.
Current Alzheimer Research
Title:Prosodic Impairment in Dementia: Review of the Literature
Volume: 15 Issue: 2
Author(s): Sylwia Misiewicz , Adam M. Brickman and Giuseppe Tosto *
Affiliation:
- G.H. Sergievsky Center, Department of Neurology, College of Physicians and Surgeons, Columbia University, New York, NY,United States
Keywords: Alzheimer's disease, dementia, frontotemporal dementia, language, mild cognitive impairment, prosody.
Abstract: Objective: Prosody, an important aspect of spoken language, is defined as the emphasis placed on certain syllables, changes in tempo or timing, and variance in pitch and intonation. Most studies investigating expression and comprehension of prosody have focused primarily on emotional prosody and less extensively on supralexical prosody. The distinction is indeed important, as the latter conveys information such as interrogative or assertive mode, whereas the former delivers emotional connotation, such as happiness, anger, and sadness. These functions appear to rely on distinct neuronal networks, supported by functional neuroimaging studies that show activation of the right hemisphere, specifically in the right inferior frontal area during emotional detection.
Conclusion: This review summarizes the studies conducted on prosody impairment in Alzheimer's disease and other dementias, with emphasis on experiments designed to investigate the emotional vs. the supralexical aspect of speech production. We also discussed the available tools validated to test and quantify the prosodic impairment.
Export Options
About this article
Cite this article as:
Misiewicz Sylwia , Brickman M. Adam and Tosto Giuseppe *, Prosodic Impairment in Dementia: Review of the Literature, Current Alzheimer Research 2018; 15 (2) . https://dx.doi.org/10.2174/1567205014666171030115624
DOI https://dx.doi.org/10.2174/1567205014666171030115624 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Which Drugs for the Control of Fever in Critical Patients
Current Drug Targets Editorial (Thematic Issue: New Therapeutic Bearings for Repositioned Drugs)
Current Topics in Medicinal Chemistry Patent Selections
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Chelating Agents for Metal Intoxication
Current Medicinal Chemistry Brain Derived Neurotrophic Factor and Cognitive Status: The Delicate Balance Among People Living with HIV, with and without Alcohol Abuse
Current HIV Research Diabetes and Complications: Cellular Signaling Pathways, Current Understanding and Targeted Therapies
Current Drug Targets Editorial [Hot Topic: Mechanisms of HIV-1 Latency Post HAART Treatment Area (Guest Editors: Lena Al-Harthi and Fatah Kashanchi)]
Current HIV Research The Emerging Role of MicroRNA in Schizophrenia
CNS & Neurological Disorders - Drug Targets Cardiovascular Complications of HIV Infection and Treatment
Cardiovascular & Hematological Agents in Medicinal Chemistry Current Limitations in the Treatment of Parkinson’s and Alzheimer’s Diseases: State-of-the-Art and Future Perspective of Polymeric Carriers
Current Medicinal Chemistry Neuronal Response of Peroxisomal and Peroxisome-Related Proteins to Chronic and Acute Aβ Injury
Current Alzheimer Research CoMFA, CoMSIA and HQSAR Studies of Acetylcholinesterase Inhibitors
Current Computer-Aided Drug Design Severe Acute Respiratory Syndrome Coronavirus 2 is Penetrating to Dementia Research
Current Neurovascular Research Cannabinoid System in Neurodegeneration: New Perspectives in Alzheimers Disease
Mini-Reviews in Medicinal Chemistry Methylated MicroRNA Genes of the Developing Murine Palate
MicroRNA Level of Knowledge About Alzheimer's Disease Among Nursing Staff in Suzhou and its Influencing Factors
Current Alzheimer Research Stress and Vulnerability Due to the Care Task: An Observational Study on Older Caregivers
Current Psychopharmacology Lafora Progressive Myoclonus Epilepsy: Recent Insights into Cell Degeneration
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Possible Drug Candidates for Alzheimers Disease Deduced from Studying their Binding Interactions with α7 Nicotinic Acetylcholine Receptor
Medicinal Chemistry Heat Shock Proteins: Therapeutic Drug Targets for Chronic Neurodegeneration?
Current Pharmaceutical Biotechnology